Merck today announced that the United States Patent and Trademark Office has granted the company’s patent for CRISPR-chrom technology.   CRISPR-chrom technology improves access to genome for more efficient editing Only U.S. patent holder in the CRISPR chromatin space Company driving innovation in CRISPR gene-editing technologies Darmstadt, Germany — Merck, a leading science and technology […]

New content and Interpret NGS analysis software detection capabilities include BCR-ABL and KMT2A-PTD detection Oxford, UK –  Oxford Gene Technology (OGT), A Sysmex Group Company, announces the addition of accurate detection capabilities for translocations and difficult-to-sequence partial tandem duplications (PTDs) in its popular myPanel™ customisable SureSeq™ NGS panels. This latest update is, for example, beneficial to researchers investigating […]

Pioneering DNA synthesis company – inventor of the Gibson Assembly method and the BioXp system – furthers its mission to empower researchers in moving from reading DNA to writing and printing DNA SAN DIEGO, California SGI-DNA, Inc. creators of the world’s first fully automated system for high-throughput writing of DNA, the BioXp 3200 system, today […]

Polyplus-transfection® SA, the leading biotechnology company that supports the gene and cell therapy market by supplying innovative transfection solutions, today announces it will make available to the market a novel transfection reagent FectoVIR®-AAV in May 2020. The reagent has been specifically developed to improve AAV (adeno-associated virus) production in suspension cell culture system for large-scale […]

The international consortium, together with the AIRR Community, is now in the process of mapping the different initiatives producing data in the context of Coronavirus, to facilitate sharing data with laboratories and health institutions. RAMAT GAN, Israel – The international iReceptor Plus consortium is offering the technology tools and infrastructure developed within the EU-funded project, to […]

New arrayed B cell CRISPR knockout screening service strengthens support for development of therapeutics for diseases involving the immune system First in the market, this unique service complements the Company’s T cell screening service Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing […]

DUBLIN, Ireland, and MILAN, Italy: ERS Genomics Limited (“ERS Genomics”), which was formed to provide broad access to the foundational CRISPR-Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Axxam S.p.A. (“Axxam”), a leading discovery biology company, today announced the signing of a license agreement granting Axxam access to ERS Genomics’ CRISPR-Cas9 patent portfolio, to support […]

SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that Fluidigm® CyTOF® technology was used in a clinical study producing preliminary evidence that mesenchymal stem cell (MSC) therapy improves outcomes in patients with COVID-19 pneumonia, providing key information about […]

BOSTON — NanoMosaic L.L.C. announced today it is commercializing technology for high-throughput, high-sensitivity analyte detection initially developed at Harvard University, through an exclusive license agreement with Harvard Office of Technology Development. NanoMosaic’s screening tools may aid in a number of biomedical fields including the early detection of disease, prognostic monitoring, biomarker discovery, and infectious disease […]

Back in September 2018, LGC acquired Lucigen Corporation. The ISO accredited site is based in Middleton, Wisconsin and employs just over 75 people. Lucigen specialises in enzymes, competent cells, and cloning systems to support applications in diagnostics, drug discovery, synthetic biology and gene editing, and now as a part of the Biosearch Technologies portfolio, is expanding […]